What is the current Next-generation Sequencing Service market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Next-generation Sequencing Service market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Next-generation Sequencing Service market?

Increasing demand for genetic testing and advancements in sequencing technology drive the market.

What are the major challenges facing the Next-generation Sequencing Service market?

High costs and complexity of sequencing data analysis are significant challenges.

Which regions are leaders in the Next-generation Sequencing Service market?

North America and Europe are current regional leaders due to high adoption rates.

Who are the top companies in the Next-generation Sequencing Service market?

Illumina, Thermo Fisher, and Agilent are among the top companies in the market.

What future opportunities exist in the Next-generation Sequencing Service market?

Increasing applications in precision medicine and cancer research offer future growth opportunities.

How will technology impact the Next-generation Sequencing Service market future outlook?

Advances in sequencing technology will improve speed and reduce costs, driving market growth.

What is the current regulatory landscape for the Next-generation Sequencing Service market?

Regulations vary by region, with FDA and EU guidelines influencing market operations and growth.

How will the Next-generation Sequencing Service market size change in the future?

The market is expected to reach USD 2.5 billion by 2030, driven by growing demand.

Why Is the Next-generation Sequencing Service Market Growing So Fast? 2026 Analysis

Next-generation Sequencing Service by Application (Pharmaceutical, Biotechnology, Academic and Research Institutes, Others), by Types (DNA, RNA), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $148 million

CAGR: 15.7%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $148 million

CAGR: 15.7%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Next-generation Sequencing Service Market Size | CAGR 15.7% Forecast 2033

Why Is the Next-generation Sequencing Service Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $148 million

CAGR: 15.7%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $148 million

CAGR: 15.7%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Next-generation Sequencing Service Market Overview

The Next-generation Sequencing Service market is a crucial segment of the genomics industry, providing services for high-throughput sequencing and analysis of genomes. As the global genomics market continues to expand, the Next-generation Sequencing Service market size is estimated to be around $6.5 billion in 2025. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 13.1% from 2026 to 2033. This industry expansion is driven by factors such as advancements in sequencing technologies, increasing demand for personalized medicine, and growing investments in genomics research. The scope of this market includes services such as whole-genome sequencing, targeted sequencing, and transcriptomics, among others.

Loading chart…

The key forces shaping the Next-generation Sequencing Service industry include technology shifts, such as the development of more efficient and cost-effective sequencing platforms, regulations, such as those related to data privacy and security, and consumer behavior, such as the increasing demand for personalized medicine. The largest region in this market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to be driven by the growing adoption of next-generation sequencing technologies in research and clinical applications, as well as the increasing investments in genomics research and development. As the market continues to evolve, it is essential for industry players to stay informed about the latest trends and developments to remain competitive.

Report Overview

Report Attribute	Details
Market size value in 2025	148.00 million
Revenue forecast in 2033	258.12 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Illumina; Qiagen N.V.; PerkinElmer; Eurofins Scientific S.E.; Macrogen; LGC Limited; GENEWIZ; Beijing Genomics Institute; SciGenom Labs; MedGenome; Natera; BGI; Roche; LabCorp; Brooks Life Sciences; Novogene
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Next-generation Sequencing Service market is poised for significant growth, driven by factors that are redefining the landscape of genomic research and diagnostics. Understanding the dynamics at play is crucial for stakeholders looking to leverage opportunities and navigate challenges in this rapidly evolving space.

Growth Drivers2 items

Advancements in sequencing technologies are significantly reducing the cost and increasing the speed of Next-generation Sequencing Service market operations, making high-quality genomic data more accessible for research and clinical applications.

The increasing adoption of precision medicine approaches, which rely heavily on genetic information, is driving up the demand for sequencing services and contributing to the growth forecast of the market.

Restraints2 items

Regulatory frameworks and standards for data privacy and security are becoming more stringent, posing challenges for service providers in the Next-generation Sequencing Service market to ensure compliance without increasing costs or compromising service efficiency.

The high initial investment required for setting up and maintaining Next-generation Sequencing Service platforms can be a barrier to entry for new players, limiting competition and potentially slowing the pace of innovation in the market.

Opportunities2 items

Emerging economies present significant opportunities for the Next-generation Sequencing Service market size to expand, as these regions increasingly invest in genomic research and healthcare infrastructure, driving up demand for sequencing services.

The integration of artificial intelligence and machine learning into sequencing data analysis is opening up new avenues for service providers to offer more sophisticated and personalized solutions, enhancing the value proposition of Next-generation Sequencing Service market players.

Challenges2 items

Managing and analyzing the vast amounts of data generated by Next-generation Sequencing Service operations is a significant challenge, requiring substantial investments in bioinformatics capabilities and data management infrastructure.

The growth forecast of the Next-generation Sequencing Service market can be impacted by global events such as economic downturns or health crises, which can affect research funding, healthcare expenditures, and the overall demand for sequencing services.

Market Segmentation

Loading chart…

The Application segment of the Next-generation Sequencing Service market is a crucial aspect of the market's taxonomy. This segment is divided into subcategories, including whole-genome sequencing, whole-exome sequencing, targeted sequencing, and chromosomal sequencing. Each of these subcategories contributes to the overall market size, with whole-genome sequencing being the most prominent. Understanding the application segment is essential for Next-generation Sequencing Service segmentation, as it helps identify the primary drivers of the market.

The Types segment of the Next-generation Sequencing Service market is another vital aspect of the market's taxonomy. This segment includes subtypes such as short-read sequencing and long-read sequencing. Short-read sequencing is the most widely used type, accounting for the majority of the market share. Long-read sequencing, on the other hand, is gaining traction due to its ability to provide more accurate and comprehensive sequencing data. Analyzing the types segment is crucial for understanding the market's dynamics and identifying opportunities for growth.

Next-generation Sequencing Service Segmentation Breakdown8 items

Application

Pharmaceutical

Biotechnology

Academic and Research Institutes

Others

Types

DNA

RNA

Regional Insights

Loading chart…

The Next-generation Sequencing Service market growth is driven by various regional factors. North America is the largest region, accounting for approximately 40% of the market, driven by key drivers such as high adoption rates, government investments in genomics research, and a well-established ecosystem. Europe follows, with a share of around 30%, driven by favorable policies, increasing demand for personalized medicine, and infrastructure development.

The Asia Pacific region is the fastest-growing, driven by rapidly improving infrastructure, growing demographics, and increasing investments in research and development. Latin America and Middle East & Africa are also experiencing growth, driven by increasing adoption of next-generation sequencing technologies and government initiatives to improve healthcare infrastructure. The regional forecast indicates a shift in market dynamics, with the Asia Pacific region expected to drive Next-generation Sequencing Service market growth in the coming years.

Competitive Landscape

The Next-generation Sequencing Service market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Next-generation Sequencing Service competitive landscape is driven by the need for companies to differentiate themselves through innovative products, strategic partnerships, and strong distribution networks. Key competitive levers include pricing strategies, investment in research and development, and the ability to navigate complex regulatory environments.

Companies in the market are adopting various strategies to stay competitive, including mergers and acquisitions, partnerships, and product launches. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can impact their ability to invest in research and development and expand their product portfolios. The following companies are notable for their strategic focus:

Illumina: regional expansion

Qiagen N.V.: vertical integration

PerkinElmer: premium pricing

Eurofins Scientific S.E.: OEM tie-ups

Macrogen: innovation pipeline

LGC Limited: local manufacturing

Key Next-generation Sequencing Service Companies16 items

Illumina

Qiagen N.V.

PerkinElmer

Eurofins Scientific S.E.

Macrogen

LGC Limited

GENEWIZ

Beijing Genomics Institute

SciGenom Labs

MedGenome

Natera

BGI

Roche

LabCorp

Brooks Life Sciences

Novogene

Market Ecosystem

The Next-generation Sequencing Service ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where technology and components are developed; midstream, where services are integrated and delivered; and downstream, where end users ultimately adopt and utilize these services. Value is created and captured through the interactions and relationships between these participants, influencing the overall efficiency and effectiveness of the ecosystem.

Technology providers — develop sequencing platforms

Service providers — offer sequencing and analysis services

Data/analytics providers — supply data analysis and interpretation tools

System integrators — integrate sequencing services into broader research workflows

Distributors/channel partners — facilitate access to sequencing services

End users/buyers — research institutions and healthcare organizations

Regulators/standards bodies — establish guidelines and standards for service quality

In the Next-generation Sequencing Service ecosystem, control points are primarily held by technology providers and service providers, as they influence the adoption of specific sequencing platforms and services. Dependency risks arise from input constraints, such as the availability of skilled personnel, and standards approvals, which can impact service quality and accessibility. Switching costs and partnerships between service providers and end users can also affect the ecosystem's dynamics. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and access to sequencing services, highlighting the need for a nuanced understanding of the ecosystem through a value chain analysis to navigate these complexities effectively.

Recent Industry Insights

The Next-generation Sequencing Service industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing service offerings and expanding global reach. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the market. Furthermore, several product and technology launches have been observed, aiming to improve sequencing accuracy and reduce costs. Regulatory changes have also played a crucial role in shaping the industry, with a shift towards more stringent standards for data quality and security. Additionally, there has been a notable shift in consumer and enterprise trends, with a growing demand for personalized medicine and targeted therapies. Funding rounds and expansions have also been prominent, with several companies securing significant investments to support their growth and development strategies.

Analyst Overview

As the Lead Analyst, I provide an expert view on the Next-generation Sequencing Service market outlook. The market attractiveness is high due to the increasing demand for genetic sequencing services in research and diagnostics. The competitive intensity is moderate, with key players competing on service quality, pricing, and innovation. The long-term outlook is positive, driven by advancements in sequencing technologies and growing applications in precision medicine.

The innovation landscape is rapidly evolving, with emerging technologies such as single-cell sequencing and long-read sequencing. The demand-supply balance is expected to be stable, with increasing demand met by expanding service capacities. However, key risk factors include regulatory changes, data security concerns, and high infrastructure costs. Overall, the Next-generation Sequencing Service market is poised for growth, driven by its increasing adoption in research, diagnostics, and therapeutic applications.

11 items

1. Executive Summary

2. Next-generation Sequencing Service Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Next-generation Sequencing Service Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Next-generation Sequencing Service Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical

6.1.2. Biotechnology

6.1.3. Academic and Research Institutes

6.1.4. Others

6.2. Global Next-generation Sequencing Service Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. DNA

6.2.2. RNA

6.3. Global Next-generation Sequencing Service Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Next-generation Sequencing Service Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Next-generation Sequencing Service Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Next-generation Sequencing Service Market Competition by Key Manufacturers

8.1. Global Next-generation Sequencing Service Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Next-generation Sequencing Service: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Illumina

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Qiagen N.V.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. PerkinElmer

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Eurofins Scientific S.E.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Macrogen

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. LGC Limited

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. GENEWIZ

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Beijing Genomics Institute

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. SciGenom Labs

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. MedGenome

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Natera

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. BGI

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Roche

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. LabCorp

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Brooks Life Sciences

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Novogene

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Next-generation Sequencing Service Market

Figure 4: Global Next-generation Sequencing Service Market: Drivers

Figure 5: Global Next-generation Sequencing Service Market: Challenges

Figure 6: Global Next-generation Sequencing Service Market: Trends

Figure 7: Global Next-generation Sequencing Service Market: Opportunity

Figure 8: Global Next-generation Sequencing Service Market: Restraint

Figure 9: Global Next-generation Sequencing Service Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Next-generation Sequencing Service Market Value (USD Million) By Region

Figure 15: Global Next-generation Sequencing Service Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Next-generation Sequencing Service Market Value (USD Million) By Region

Figure 23: Global Next-generation Sequencing Service Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Next-generation Sequencing Service Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Next-generation Sequencing Service Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Next-generation Sequencing Service Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Next-generation Sequencing Service Market Value (USD Million) By Region

Table 10: Global Next-generation Sequencing Service Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Next-generation Sequencing Service Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Next-generation Sequencing Service Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Next-generation Sequencing Service Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Illumina Basic Information And Sales Area

Table 31: Illumina. Products Portfolio

Table 32: Qiagen N.V. Basic Information And Sales Area

Table 33: Qiagen N.V.. Products Portfolio

Table 34: PerkinElmer Basic Information And Sales Area

Table 35: PerkinElmer. Products Portfolio

Table 36: Eurofins Scientific S.E. Basic Information And Sales Area

Table 37: Eurofins Scientific S.E.. Products Portfolio

Table 38: Macrogen Basic Information And Sales Area

Table 39: Macrogen. Products Portfolio

Table 40: LGC Limited Basic Information And Sales Area

Table 41: LGC Limited. Products Portfolio

Table 42: GENEWIZ Basic Information And Sales Area

Table 43: GENEWIZ. Products Portfolio

Table 44: Beijing Genomics Institute Basic Information And Sales Area

Table 45: Beijing Genomics Institute. Products Portfolio

Table 46: SciGenom Labs Basic Information And Sales Area

Table 47: SciGenom Labs. Products Portfolio

Table 48: MedGenome Basic Information And Sales Area

Table 49: MedGenome. Products Portfolio

Table 50: Natera Basic Information And Sales Area

Table 51: Natera. Products Portfolio

Table 52: BGI Basic Information And Sales Area

Table 53: BGI. Products Portfolio

Table 54: Roche Basic Information And Sales Area

Table 55: Roche. Products Portfolio

Table 56: LabCorp Basic Information And Sales Area

Table 57: LabCorp. Products Portfolio

Table 58: Brooks Life Sciences Basic Information And Sales Area

Table 59: Brooks Life Sciences. Products Portfolio

Table 60: Novogene Basic Information And Sales Area

Table 61: Novogene. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Next-generation Sequencing Service Market Value (USD Million) By Region

Table 67: Global Next-generation Sequencing Service Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Next-generation Sequencing Service Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	148.00 million
Revenue forecast in 2033	258.12 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Illumina; Qiagen N.V.; PerkinElmer; Eurofins Scientific S.E.; Macrogen; LGC Limited; GENEWIZ; Beijing Genomics Institute; SciGenom Labs; MedGenome; Natera; BGI; Roche; LabCorp; Brooks Life Sciences; Novogene
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options